China's Hutchison MediPharma Phase IIb Trials In Ulcerative Colitis Meet Primary, Secondary Endpoints
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm aims to partner for Phase III development of HMPL-004, particularly in the U.S. and Europe. "We are flexible in terms of partnerships, whether they are co-development or co-promotional in nature," CEO says..